Anbenitamab Unknown Status Phase 2 Trials for Gastroesophageal Junction Cancer / Gastric Cancer / Gastric and Gastroesophageal Junction Cancer Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03925974KN026 in Patients With HER2 Expressing Gastric/Gastroesophageal Junction Cancer